The role of IL-6 and osteoprotegerin in bone metabolism in patients with Graves' disease.

Omma, Tülay; Yücel, Çigdem; Sertoglu, Erdim; Firat, Sevde Nur; Çulha, Cavit; Özgürtas, Taner

Omma, Tülay; Yücel, Çigdem; Sertoglu, Erdim; Firat, Sevde Nur; Çulha, Cavit; Özgürtas, Taner.

Afiliação

Omma T; Department of Endocrinology and Metabolism, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Yücel Ç; Department of Clinical Biochemistry, Ankara Numune Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Sertoglu E; Department of Clinical Biochemistry, Ankara Gülhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Firat SN; Department of Endocrinology and Metabolism, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Çulha C; Department of Endocrinology and Metabolism, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Özgürtas T; Department of Clinical Biochemistry, Ankara Gülhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

Turk J Med Sci ; 52(2): 338-345, 2022 Apr.

Article em En | MEDLINE | ID: mdl-36161625

Assuntos

Doença de Graves; Hipertireoidismo; Hormônios; Humanos; Interleucina-6; Ligantes; NF-kappa B; Osteoprotegerina; Ligante RANK; Hormônios Tireóideos; Tireotropina

Palavras-chave

Graves' disease; interleukin-6; osteoprotegerin; receptor activator of NF-kB ligand

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Graves / Hipertireoidismo Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Graves / Hipertireoidismo Idioma: En Ano de publicação: 2022 Tipo de documento: Article